Related Experiment Video
Updated: Dec 10, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic virus therapy benefits from control theory
Anet J N Anelone1, María F Villa-Tamayo2, Pablo S Rivadeneira2
1School of Mathematics and Statistics, The University of Sydney, Camperdown, New South Wales 2006, Australia.
Mathematical modeling and control theory reveal that at least three viral injections are needed for effective oncolytic virus therapy. This approach optimizes viral dosage for improved tumor regression and treatment robustness.
Area of Science:
- Oncology
- Virology
- Control Theory
- Mathematical Biology
Background:
- Oncolytic virus therapy utilizes viruses to selectively destroy cancer cells.
- Optimizing treatment protocols, including viral dose and schedule, is crucial for effective tumor eradication.
- Mathematical modeling aids in understanding and predicting the outcomes of oncolytic virus therapy.
Purpose of the Study:
- To apply control theory to a mathematical model of oncolytic virus therapy.
- To determine optimal viral injection strategies for tumor regression.
- To enhance the efficiency and robustness of oncolytic virus treatments.
Main Methods:
- Development and analysis of a mathematical model for oncolytic virus therapy.
- Application of control theory, including impulsive control and state feedback control.
- In silico evaluation of the proposed control strategy using parameters from experimental data.
Main Results:
- Control analysis indicates a minimum of three viral injections are necessary for tumor control.
- An impulsive control strategy with integral action and state feedback was developed.
- In silico simulations demonstrated that feedback control optimizes viral dosage for improved tumor regression and robustness.
Conclusions:
- Control theory offers significant theoretical and practical benefits for advancing oncolytic virus therapy.
- The proposed feedback control strategy can lead to more efficient and personalized viral dosing.
- This approach has the potential to improve treatment outcomes compared to previous protocols.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

